Tizanidine Hydrochloride Capsule
Product Images NDC 85742-033

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 85742-033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kanchan Healthcare Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cont-label-2-mg-150-capsules (Cont Label 2 mg 150 Capsules)

Label for Tizanidine Hydrochloride Capsules 2 mg from Kanchan Healthcare Inc. The label shows the capsule strength (2 mg), package count (150 capsules), and caution not to mix with tizanidine tablets or Zanaflex tablets. It includes storage instructions and manufacturer details from Cadila Pharmaceuticals Limited, India, and marketing info for Kanchan Healthcare Inc, USA.*

FDA Label Image

Cont-label-4-mg-150-capsules (Cont Label 4 mg 150 Capsules)

Tizanidine Hydrochloride Capsules 4 mg oral dosage form, label shows a bottle with 150 capsules. The label states the active ingredient amount per capsule as 4.58 mg tizanidine hydrochloride equivalent to 4 mg tizanidine base. Manufactured by Cadila Pharmaceuticals Limited, India, and marketed by Kanchan Healthcare Inc. The label includes storage instructions, a child-resistant container warning, and a statement not to interchange with tizanidine tablets or Zanaflex tablets.*

FDA Label Image

Cont-label-6-mg-150-capsules (Cont Label 6 mg 150 Capsules)

Label for Tizanidine Hydrochloride Capsules 6 mg by Kanchan Healthcare Inc. The label displays 150 capsules and indicates the dosage strength as 6 mg. It includes storage instructions, a caution to keep medication out of reach of children, manufacturing details by Cadila Pharmaceuticals Limited, and the distributor's address in Parsippany, NJ. The label also features a barcode and a prominent 'Rx only' symbol.*

FDA Label Image

Tizanidine-spl-structure (Structure Tizanidine)

Chemical structure diagram of tizanidine hydrochloride, illustrating its molecular composition including a chlorinated aromatic ring, a thiazole moiety, and a pyrrolidine ring, showing the arrangement of nitrogen, sulfur, chlorine, and hydrogen atoms.*

FDA Label Image

Figure-1 (Tizanidine Spl Fig 1)

A line graph showing plasma concentration of Tizanidine hydrochloride (ng/ml) over time (hours from dosing). The graph compares 2 x 4 mg doses of Tizanidine tablets and capsules with and without food, illustrating changes in plasma concentration within 24 hours post-dose.*

FDA Label Image

Figure-2 (Tizanidine Spl Fig 2)

A line graph depicting improvement in Ashworth Score over 6 hours post-dose. It compares three groups: placebo, 8 mg tizanidine, and 16 mg tizanidine, showing higher improvement for tizanidine doses than placebo with peak effects between 1 and 3 hours.*

FDA Label Image

Figure-3 (Tizanidine Spl Fig 3)

A graph showing improvement in Ashworth Score over time comparing tizanidine (mean dose 28.8 mg) with placebo across three study points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Error bars indicate variability.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.